POMC and Cowden disease: The possibility to perform preclinical studies on animal models that recapitulate CD clinical and molecular features provides a unique opportunity to gain insights into its pathogenic mechanisms, investigate the systemic effects of ACTH and glucocorticoids (GCs) deregulation, and develop new therapeutic strategies, especially given the lack of human ACTH-producing cell lines for in vitro research [2].